The current valuation score of Evogene Ltd is 6.99, ranking 258 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -0.46, which is -94.31% below the recent high of -0.03 and -1725.06% above the recent low of -8.38.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.